211 related articles for article (PubMed ID: 12948278)
21. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
Mirsaeidi SM; Tabarsi P; Khoshnood K; Pooramiri MV; Rowhani-Rahbar A; Mansoori SD; Masjedi H; Zahirifard S; Mohammadi F; Farnia P; Masjedi MR; Velayati AA
Int J Infect Dis; 2005 Nov; 9(6):317-22. PubMed ID: 16183321
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
23. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
[TBL] [Abstract][Full Text] [Related]
24. [Combination chemotherapy of drug-resistant tuberculosis with inclusion of ofloxacin (zanocin)].
Padeĭskaia EN
Antibiot Khimioter; 2001; 46(8):9-18. PubMed ID: 11871320
[No Abstract] [Full Text] [Related]
25. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of pyrazinamide in children suffering from pulmonary tuberculosis.
Roy V; Tekur U; Chopra K
Int J Tuberc Lung Dis; 1999 Feb; 3(2):133-7. PubMed ID: 10091878
[TBL] [Abstract][Full Text] [Related]
28. Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent.
Verho M; Malerczyk V; Dagrosa E; Korn A
Pharmatherapeutica; 1985; 4(6):376-82. PubMed ID: 3866256
[TBL] [Abstract][Full Text] [Related]
29. [A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis].
Chen QL; Chen L; Yin JJ
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Aug; 26(8):454-7. PubMed ID: 14505519
[TBL] [Abstract][Full Text] [Related]
30. Use of nonlinear, mixed-effects modeling for population analysis of ofloxacin: effects of age on oral drug pharmacokinetics.
Yuen GJ; Drusano GL; Brooks J; Flor S
Pharmacotherapy; 1992; 12(2):88-92. PubMed ID: 1570232
[TBL] [Abstract][Full Text] [Related]
31. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
32. Levofloxacin pharmacokinetics in children.
Chien S; Wells TG; Blumer JL; Kearns GL; Bradley JS; Bocchini JA; Natarajan J; Maldonado S; Noel GJ
J Clin Pharmacol; 2005 Feb; 45(2):153-60. PubMed ID: 15647407
[TBL] [Abstract][Full Text] [Related]
33. Ofloxacin induced arthropathy in patients with multi-drug resistance tuberculosis.
Tumbanatham A; Vinodkumar S
J Assoc Physicians India; 2000 Jun; 48(6):647-8. PubMed ID: 11273550
[TBL] [Abstract][Full Text] [Related]
34. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
35. Disposition of uric acid upon administration of ofloxacin alone and in combination with other anti-tuberculosis drugs.
Kumar AK; Gurumurthy P
Indian J Exp Biol; 2004 Mar; 42(3):323-5. PubMed ID: 15233305
[TBL] [Abstract][Full Text] [Related]
36. Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants.
Ward HA; Marciniuk DD; Hoeppner VH; Jones W
Int J Tuberc Lung Dis; 2005 Feb; 9(2):164-9. PubMed ID: 15732735
[TBL] [Abstract][Full Text] [Related]
37. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
[TBL] [Abstract][Full Text] [Related]
38. Correlation of serum ofloxacin concentration and serum creatinine level in patients on prolonged therapy.
Yew WW; Wong CF; Wong PC; Cheung SW; Chan CY; Cheng AF
Int J Clin Pharmacol Res; 1993; 13(5):243-5. PubMed ID: 8200719
[TBL] [Abstract][Full Text] [Related]
39. Severe arthropathy with ofloxacin in two cases of MDR tuberculosis.
Arora VK; Tumbanatham A
Int J Tuberc Lung Dis; 1998 Nov; 2(11):941-3. PubMed ID: 9848618
[No Abstract] [Full Text] [Related]
40. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
Akkan AG; Mutlu I; Ozyazgan S; Gök A; Yigit U; Ozüner Z; Senses V; Pekel H
Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
